| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.2 | 5e-09 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.17 | 3e-07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.001 |